{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-024878","form_type":"8-K","ticker":"VKTX","cik":"0001607678","company_name":"Viking Therapeutics, Inc.","filed_at":"2024-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.795209+00:00","generated_at":"2026-06-05T04:44:17.166530+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Viking Therapeutics closes $632.5M public offering of 7.44M shares at $85.00","bullets":["Closed public offering of 7,441,650 shares at $85.00 each, including full exercise of underwriters' option for 970,650 additional shares.","Gross proceeds of approximately $632.5 million before underwriting discounts and offering expenses.","Net proceeds will fund continued development of VK2809, VK2735, VK0214 programs and general corporate purposes.","Joint book-running managers: Morgan Stanley, Leerink Partners, William Blair, Raymond James, Stifel, Truist Securities."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-024878","json":"https://secwatch.observer/filing/0000950170-24-024878.json","markdown":"https://secwatch.observer/filing/0000950170-24-024878.md","text":"https://secwatch.observer/filing/0000950170-24-024878.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1607678/000095017024024878/0000950170-24-024878-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1607678/000095017024024878/vktx-20240304.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T04:44:17.166530+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}